150 related articles for article (PubMed ID: 1746424)
1. Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE).
Sacks FM; Pfeffer MA; Moye' L; Brown LE; Hamm P; Cole TG; Hawkins CM; Braunwald E
Am J Cardiol; 1991 Dec; 68(15):1436-46. PubMed ID: 1746424
[TBL] [Abstract][Full Text] [Related]
2. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.
Lewis SJ; Sacks FM; Mitchell JS; East C; Glasser S; Kell S; Letterer R; Limacher M; Moye LA; Rouleau JL; Pfeffer MA; Braunwald E
J Am Coll Cardiol; 1998 Jul; 32(1):140-6. PubMed ID: 9669262
[TBL] [Abstract][Full Text] [Related]
3. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.
Lewis SJ; Moye LA; Sacks FM; Johnstone DE; Timmis G; Mitchell J; Limacher M; Kell S; Glasser SP; Grant J; Davis BR; Pfeffer MA; Braunwald E
Ann Intern Med; 1998 Nov; 129(9):681-9. PubMed ID: 9841599
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators.
Wanner C; Krane V; Ruf G; März W; Ritz E
Kidney Int Suppl; 1999 Jul; 71():S222-6. PubMed ID: 10412782
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.
Pfeffer MA; Sacks FM; Moyé LA; Brown L; Rouleau JL; Hartley LH; Rouleau J; Grimm R; Sestier F; Wickemeyer W
Am J Cardiol; 1995 Sep; 76(9):98C-106C. PubMed ID: 7572695
[TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering drug use and cardiovascular events after myocardial infarction.
Klungel OH; Heckbert SR; de Boer A; Leufkens HG; Sullivan SD; Fishman PA; Veenstra DL; Psaty BM
Ann Pharmacother; 2002 May; 36(5):751-7. PubMed ID: 11978147
[TBL] [Abstract][Full Text] [Related]
7. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators.
Flaker GC; Warnica JW; Sacks FM; Moyé LA; Davis BR; Rouleau JL; Webel RR; Pfeffer MA; Braunwald E
J Am Coll Cardiol; 1999 Jul; 34(1):106-12. PubMed ID: 10399998
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators.
Goldberg RB; Mellies MJ; Sacks FM; Moyé LA; Howard BV; Howard WJ; Davis BR; Cole TG; Pfeffer MA; Braunwald E
Circulation; 1998 Dec; 98(23):2513-9. PubMed ID: 9843456
[TBL] [Abstract][Full Text] [Related]
9. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.
Sacks FM; Pfeffer MA; Moye LA; Rouleau JL; Rutherford JD; Cole TG; Brown L; Warnica JW; Arnold JM; Wun CC; Davis BR; Braunwald E
N Engl J Med; 1996 Oct; 335(14):1001-9. PubMed ID: 8801446
[TBL] [Abstract][Full Text] [Related]
10. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
[TBL] [Abstract][Full Text] [Related]
11. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.
Rouleau J
Am J Med; 2005 Dec; 118 Suppl 12A():28-35. PubMed ID: 16356805
[TBL] [Abstract][Full Text] [Related]
12. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.
Hunt D; Young P; Simes J; Hague W; Mann S; Owensby D; Lane G; Tonkin A
Ann Intern Med; 2001 May; 134(10):931-40. PubMed ID: 11352694
[TBL] [Abstract][Full Text] [Related]
13. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
[TBL] [Abstract][Full Text] [Related]
14. The anatomy of a clinical trial. The West of Scotland Coronary Prevention Study.
Shepherd J; Gaw A;
Med Princ Pract; 2002; 11 Suppl 2():17-30. PubMed ID: 12444307
[TBL] [Abstract][Full Text] [Related]
15. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
Hague W; Forder P; Simes J; Hunt D; Tonkin A;
Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
[TBL] [Abstract][Full Text] [Related]
16. Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).
Ital Heart J; 2000 Dec; 1(12):810-20. PubMed ID: 11302109
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.
Sacks FM; Moyé LA; Davis BR; Cole TG; Rouleau JL; Nash DT; Pfeffer MA; Braunwald E
Circulation; 1998 Apr; 97(15):1446-52. PubMed ID: 9576424
[TBL] [Abstract][Full Text] [Related]
18. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E
J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923
[TBL] [Abstract][Full Text] [Related]
19. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency.
Tonelli M; Moyé L; Sacks FM; Kiberd B; Curhan G;
Ann Intern Med; 2003 Jan; 138(2):98-104. PubMed ID: 12529091
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
